Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development
28/05/2026 15:33
BRIEF-Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development May 28 (Reuters) - Dyadic International Inc DYAI.O:
DYADIC AND SCRIPPS RESEARCH COLLABORATE ON RAPID-RESPONSE HANTAVIRUS ANTIBODY AND VACCINE DEVELOPMENT
DYADIC INTERNATIONAL -CO AND SCRIPPS TO SEEK PARTNERSHIPS AND NON-DILUTIVE FUNDING FOR ANTIBODY AND VACCINE DEVELOPMENT
Source text: ID:nGNX1S1FWb
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development